Citizens Initiates Ascentage Pharma Group at Market Outperform
Citizens initiated coverage of Ascentage Pharma Group with a Market Outperform rating and a $35.00-per-share price target.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Citizens Initiates Ascentage Pharma Coverage With Market Outperform Rating
Citizens set a $35 price target for Ascentage Pharma Group, implying 19.5% upside from the Oct. 13 close of $29.30.